PAM
Paradigm Asset Management Portfolio holdings
AUM
$405M
1-Year Return
15.78%
This Quarter Return
+8.59%
1 Year Return
+15.78%
3 Year Return
+47.15%
5 Year Return
+99.02%
10 Year Return
+216.38%
AUM
$356M
AUM Growth
+$56.4M
(+19%)
Cap. Flow
+$19.5M
Cap. Flow
% of AUM
5.46%
Top 10 Holdings %
Top 10 Hldgs %
14.42%
Holding
550
New
79
Increased
181
Reduced
93
Closed
43
Top Buys
| 1 |
Microsoft
MSFT
|
$7.07M |
| 2 |
Johnson & Johnson
JNJ
|
$4.17M |
| 3 |
CVS Health
CVS
|
$4M |
| 4 |
Chevron
CVX
|
$3.52M |
| 5 |
Apple
AAPL
|
$3.43M |
Top Sells
| 1 |
Devon Energy
DVN
|
$9.13M |
| 2 |
Applied Materials
AMAT
|
$3.75M |
| 3 |
Bristol-Myers Squibb
BMY
|
$3.69M |
| 4 |
Cigna
CI
|
$3.26M |
| 5 |
NOV
NOV
|
$3.06M |
Sector Composition
| 1 | Financials | 13.14% |
| 2 | Healthcare | 10.72% |
| 3 | Technology | 8.72% |
| 4 | Industrials | 7.54% |
| 5 | Energy | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
CME Group
CME
$94.4B
| $639K | 0.18% |
3,800
+2,800
| +280% | +$471K |
|
127
Costco
COST
$427B
| $630K | 0.18% |
1,381
-5,100
| -79% | -$2.33M |
|
128
TJX Companies
TJX
$155B
| $610K | 0.17% |
7,660
-13,920
| -65% | -$1.11M |
|
129
Mastercard
MA
$528B
| $591K | 0.17% |
1,699
-1,500
| -47% | -$522K |
|
130
RTX Corp
RTX
$211B
| $516K | 0.14% |
5,113
-24,200
| -83% | -$2.44M |
|
131
Lowe's Companies
LOW
$151B
| $513K | 0.14% |
2,573
-9,600
| -79% | -$1.91M |
|
132
Progressive
PGR
$143B
| $506K | 0.14% |
3,900
-2,800
| -42% | -$363K |
|
|
133
Devon Energy
DVN
$22.1B
| $500K | 0.14% |
8,130
-148,400
| -95% | -$9.13M |
|
134
Cardinal Health
CAH
$35.7B
| $484K | 0.14% |
+6,300
| New | +$484K |
|
135
Ross Stores
ROST
$49.4B
| $464K | 0.13% |
4,000
+1,700
| +74% | +$197K |
|
136
Cencora
COR
$56.7B
| $464K | 0.13% |
+2,800
| New | +$464K |
|
137
Stryker
SYK
$150B
| $440K | 0.12% |
1,800
+300
| +20% | +$73.3K |
|
138
O'Reilly Automotive
ORLY
$89B
| $422K | 0.12% |
7,500
| – | – |
|
139
Intercontinental Exchange
ICE
$99.8B
| $383K | 0.11% |
3,731
-7,700
| -67% | -$790K |
|
140
Novartis
NVS
$251B
| $382K | 0.11% |
4,213
| – | – |
|
141
NVIDIA
NVDA
$4.07T
| $380K | 0.11% |
25,970
-52,000
| -67% | -$760K |
|
142
Labcorp
LH
$23.2B
| $377K | 0.11% |
1,864
-7,682
| -80% | -$1.55M |
|
143
Gilead Sciences
GILD
$143B
| $369K | 0.1% |
+4,300
| New | +$369K |
|
144
Cintas
CTAS
$82.4B
| $361K | 0.1% |
3,200
+800
| +33% | +$90.3K |
|
145
Roper Technologies
ROP
$55.8B
| $346K | 0.1% |
800
-200
| -20% | -$86.4K |
|
146
Microchip Technology
MCHP
$35.6B
| $337K | 0.09% |
4,800
+100
| +2% | +$7.03K |
|
147
Revvity
RVTY
$10.1B
| $337K | 0.09% |
2,400
+500
| +26% | +$70.1K |
|
148
Walt Disney
DIS
$212B
| $330K | 0.09% |
+3,800
| New | +$330K |
|
149
APA Corp
APA
$8.14B
| $322K | 0.09% |
6,900
+1,500
| +28% | +$70K |
|
150
Factset
FDS
$14B
| $321K | 0.09% |
+800
| New | +$321K |
|